Uvavanyo olukhawulezayo lwe-Fetal Fibronectin
UKUSETYENZISWA EKUJOLISWE KUYO
Inyathelo Eliqinileyo®Uvavanyo lwe-PROM luvavanyo lwe-immunochromatographic olutolikwa ngokubonakalayo ekujongwe ukuba lusetyenziselwe ukubonwa komgangatho we-fibronectin yosana kwimfihlo yomlomo wesibeleko.Ubukho be-fibronectin yomntwana kwi-cervicovaginal secretions phakathi kweeveki ezingama-22, iintsuku ezi-0 kunye neeveki ezingama-34, iintsuku ezi-6 zokumithaezinxulumene nomngcipheko ophakamileyo wokuhanjiswa kwangaphambili.
INTSHAYELELO
Ukunikezelwa kwangaphambili, okuchazwa yi-American College of Obstetricians kunye neGynecologists njengokunikezelwa ngaphambi kweveki ye-37 yokukhulelwa, inoxanduva lobuninzi be-non-chromosomal perinatal morbidity kunye nokufa.Iimpawu ezisongelwayo zonikezelo lwangaphambi kwexesha zibandakanya ukuqhawuka kwesibeleko, utshintsho lokuphuma kwilungu lobufazi, ukopha kwilungu lobufazi, umqolo obuhlungu, ukungonwabi kwesisu, uxinzelelo lwe-pelvic, kunye nokuqhekeka.Iindlela zokuxilonga zokuchongwa kokunikezelwa kwangaphambili okusongelayo ziquka ukubeka iliso komsebenzi wesibeleko kunye nokusebenza kovavanyo lomlomo wesibeleko lwedijithali, oluvumela ukuqikelelwa kwemilinganiselo yomlomo wesibeleko.Ezi ndlela zibonakaliswe ukuba zincinci, njengoko ukuhlanjululwa komlomo wesibeleko kuncinci (
I-Fetal fibronectin (fFN), i-isoform ye-fibronectin, i-adhesive glycoprotein eyinkimbinkimbi ene-molecular weight malunga ne-500,000 daltons.UMatsuura kunye nabasebenzi abasebenzisana nabo baye bachaza i-antibody ye-monoclonal ebizwa ngokuba yi-FDC-6, eqaphela ngokukodwa i-III-CS, ummandla ochaza i-isoform ye-fetus ye-fibronectin.Izifundo ze-Immunohistochemical ze-placenta zibonise ukuba i-fFN iuvalelwe kwi-matrix engaphandle kwendawo echaza i-junctionIyunithi yomama kunye neyomntwana ngaphakathi kwesibeleko.
I-fibronectin ye-Fetal inokubonwa kwi-cervicovaginal secretions yabasetyhini ngexesha lonke lokukhulelwa ngokusebenzisa i-monoclonal antibodybased immunoassay.I-fibronectin ye-Fetal inyuswa kwi-cervicovaginal secretions ngexesha lokukhulelwa kokuqala kodwa iyancipha ukusuka kwiiveki ezingama-22 ukuya kwezingama-35 ekukhulelweni okuqhelekileyo.Ukubaluleka kobukho bayo kwisini ngexesha leeveki zokuqala zokukhulelwa akuqondwa.Nangona kunjalo, inokubonisa nje ukukhula okuqhelekileyo kwe-extravillous trophoblast yabemi kunye ne-placenta.Ukufunyanwa kwe-fFN kwimfihlo yomlomo wesibeleko phakathi kweeveki ezingama-22, iintsuku ezi-0 kunye neeveki ezingama-34, iintsuku ezi-6 zokumitha zichazwe ukuba zidibene nokuhanjiswa kwangaphambili kweempawu kunye naphakathi kweeveki ezingama-22, iintsuku ezi-0 kunye neeveki ezingama-30, iintsuku ezi-6 kubasetyhini abakhulelweyo abangenazimpawu.
UMGAQO
Inyathelo Eliqinileyo®Uvavanyo lwe-fFN lusebenzisa umbala we-immunochromatographic, iteknoloji yokuhamba kwe-capillary.Inkqubo yovavanyo ifuna ukunyibilikiswa kwe-fFN kwiswabhu yelungu lobufazi ngokuxuba iswab kwiSampuli yesithinteli.Emva koko i-buffer yesampuli edibeneyo yongezwa kwisampuli yekhasethi yovavanyo kakuhle kwaye umxube ufuduka ecaleni komphezulu we-membrane.Ukuba i-fFN ikhona kwisampulu, iya kwenza i-complex kunye ne-anti-fFN antibody ephambili edityaniswe kumasuntswana anemibala.I-complex iya kuthi emva koko ibotshwe sisilwanyane se-anti-fN sesibini esigqunywe kwinwebu ye-nitrocellulose.Ukubonakala komgca wovavanyo olubonakalayo kunye nomgca wokulawula kuya kubonisa umphumo omuhle.
AMANQAKU EKIT
| 20 Umntu ngamnye packizixhobo zovavanyo lwe-ed | Isixhobo ngasinye sinomgca onama-conjugates anemibala kunye nee-reagents ezisebenzayo ezifakwe ngaphambili kwiindawo ezihambelanayo. |
| 2UkutsalwaBuffer vial | I-0.1 M I-Phosphate buffered saline (PBS) kunye ne-0.02% ye-sodium azide. |
| 1 I-swab yolawulo oluhle (ngesicelo kuphela) | Ziqulethe i-fFN kunye ne-azide ye-sodium.Kulawulo lwangaphandle. |
| 1 Iswab yokulawula engalunganga (ngesicelo kuphela) | Ayiqulathanga i-fFN.Kulawulo lwangaphandle. |
| 20 Imibhobho yokukhupha | Ukulungiselela imizekelo yokusetyenziswa. |
| 1 Indawo yokusebenzela | Indawo yokugcina i-buffer vials kunye netyhubhu. |
| 1 Faka iphakheji | Ngomyalelo wokusebenza. |
IZINTO EZIFUNEKAYO KODWA AKUNIKEZWE
| Isibali-xesha | Ukusetyenziswa kwexesha. |
UKULUMKELA
■ Ukusetyenziswa koxilongo lwe-in vitro kuphela.
■ Musa ukusebenzisa emva komhla wokuphelelwa kwawo oboniswe kwiphakheji.Musa ukulusebenzisa uvavanyo ukuba isingxobo sefoyile saso sonakalisiwe.Musa ukuphinda usebenzise iimvavanyo.
∎ Le khithi iqulethe iimveliso zezilwanyana.Ulwazi oluqinisekisiweyo lwemvelaphi kunye / okanye ubume bococeko lwezilwanyana aluqinisekisi ngokupheleleyo ukungabikho kwee-agent ze-pathogenic ezihambisayo.Kuyacetyiswa ke ngoko ukuba ezi mveliso ziphathwe njengenokosulela, kwaye ziphathwe ngokuqwalasela imiqathango yokhuseleko yesiqhelo (ungagilisi okanye ukusezele umoya).
■ Kuphephe ukungcoliseka ngokunqamlezileyo kwesampulu ngokusebenzisa isikhongozeli esitsha somfanekiso womfanekiso ofunyenweyo.
■ Funda inkqubo yonke ngocoselelo phambi kokwenza naluphi na uvavanyo.
∎ Ungatyi, ungaseli okanye utshaye kwindawo apho imizekelo neekhithi ziphathwa.Phatha yonke imizekelo ngokungathi inee-arhente ezosulelayo.Qwalasela izilumkiso ezimiselweyo malunga nobungozi be-microbiological kuyo yonke inkqubo kwaye ulandele iinkqubo ezisemgangathweni zokulahla ngokufanelekileyo iisampulu.Nxiba iimpahla ezikhuselayo ezifana needyasi zaselabhoratri, iiglavu ezilahlwayo kunye nokhuseleko lwamehlo xa imizekelo ivavanywa.
■ Musa ukutshintshiselana okanye uxube ii-reagents ezivela kwiindawo ezahlukeneyo.Musa ukuxuba iminqwazi yebhotile yesisombululo.
∎ Ukufuma kunye nobushushu bunokuba nefuthe elibi kwiziphumo.
∎ Xa inkqubo yokuvavanya igqityiwe, lahla i-swabs ngononophelo emva kokuba i-autoclaving kubo kwi-121 ° C ubuncinane imizuzu engama-20.Kungenjalo, banokunyangwa nge-0.5% ye-sodium hypochloride (okanye i-bleach-hold house) iyure enye ngaphambi kokulahlwa.Izinto zokuvavanya ezisetyenzisiweyo kufuneka zilahlwe ngokuhambelana nemigaqo yasekhaya, yelizwe kunye / okanye ye-federal.
■ Musa ukusebenzisa iibrashi ze-cytology kunye nezigulane ezikhulelweyo.
UKUGCINWA NOZINZI
∎ Ikhithi kufuneka igcinwe kwi-2-30°C de kube ngumhla wokuphelelwa kwexesha uprintwe kwisingxobo esivaliweyo.
■ Uvavanyo kufuneka luhlale kwisingxobo esivaliweyo de lusetyenziswe.
■ Musa ukuba ngumkhenkce.
∎ Iinkathalo kufuneka zithathwe ukukhusela amalungu ale khithi ekosulelweni.Musa ukusebenzisa ukuba kukho ubungqina bokungcoliseka kwe-microbial okanye imvula.Ungcoliseko lwebhayoloji lwezixhobo zokukhupha, izikhongozeli okanye iirejenti kunokukhokelela kwiziphumo ezingezizo.
UKUQOKELELWA KWEPECIMN NOKUGCINWA
■ Sebenzisa kuphela i-Dacron okanye i-Rayon eneencam ezinencapha ezichuliweyo ezineeshafu zeplastiki.Kucetyiswa ukuba usebenzise i-swab ebonelelwe ngumenzi wekhithi (Ii-swabs aziqulathanga kule khithi, ngolwazi lokuodola, nceda uqhagamshelane nomenzi okanye umsasazi wendawo, inombolo yekhathalogu yi-207000).Iiswabs ezivela kwabanye ababoneleli azikaqinisekiswa.I-swabs eneengcebiso zekotoni okanye i-shafts yokhuni ayikhuthazwa.
∎ Ukukhutshwa kwe-Cervicovaginal secretions kufunyanwa kwi-fornix yangasemva yelungu lobufazi.Inkqubo yokuqokelela ijonge ukuba ibe mnene.Ukuqokelela okunamandla okanye okunamandla, okuqhelekileyo kwiinkcubeko ze-microbiological, akufuneki.Ngexesha lovavanyo lwe-speculum, phambi kovavanyo okanye ukuguqulwa komlomo wesibeleko okanye i-vaginal tract, jikelezisa kancinci incam yesifaki kwi-fornix yangasemva yelungu lobufazi malunga nemizuzwana ye-10 ukufunxa incindi yomlomo wesibeleko.Iinzame ezilandelayo zokuzalisa ingcebiso yomfaki-sicelo zinokuluphelisa uvavanyo.Susa umfaki-sicelo kwaye wenze uvavanyo njengoko kuchaziwe ngezantsi.
■ Beka i-swab kwityhubhu yokukhupha, ukuba uvavanyo lunokwenziwa ngokukhawuleza.Ukuba uvavanyo olukhawulezileyo alunakwenzeka, iisampuli zesigulane kufuneka zifakwe kwi-tube yokuthutha eyomileyo yokugcina okanye ukuthutha.Iiswabs zinokugcinwa iiyure ezingama-24 kwiqondo lobushushu legumbi (15-30°C) okanye iveki enye kwi-4°C okanye hayi ngaphezulu kweenyanga ezi-6 kwi-20°C.Zonke iisampuli kufuneka zivunyelwe ukufikelela kwiqondo lokushisa kwe-15-30 ° C ngaphambi kokuvavanya.
INKQUBO
Zisa iimvavanyo, imizekelo, isithinteli kunye/okanye nolawulo kwiqondo lobushushu begumbi (15-30°C) phambi kokusetyenziswa.
■ Beka ityhubhu ecocekileyo yokutsalwa kwindawo echongiweyo yendawo yokusebenza.Yongeza i-1ml ye-Extraction Buffer kwityhubhu yokukhupha.
■ Faka i-swab yomzekelo kwityhubhu.Hlanganisa ngamandla isisombululo ngokujikeleza i-swab ngamandla kwicala letyhubhu ubuncinane amaxesha alishumi (ngelixa lifakwe emanzini).Iziphumo ezilungileyo zifumaneka xa i-specimen ixutywe ngamandla kwisisombululo.
∎ Khupha ulwelo oluninzi kangangoko kunokwenzeka kwiswab ngokucinezela icala letyhubhu ethambileyo yokutsalwa njengoko kususwa iswab.Ubuncinci i-1/2 yesisombululo se-buffer yesampuli kufuneka ihlale kwi-tube ukwenzela ukuba ukufuduka okwaneleyo kwe-capillary kwenzeke.Beka ikepusi kwityhubhu ekhutshiweyo.
Lahla i-swab kwisikhongozeli esifanelekileyo senkunkuma ye-biohazardous.
∎ Imizekelo ekhutshiweyo inokugcina ubushushu begumbi imizuzu engama-60 ngaphandle kokuchaphazela iziphumo zovavanyo.
■ Susa uvavanyo kwisingxobo salo esivaliweyo, kwaye ulubeke kwindawo ecocekileyo, ethe tyaba.Faka ileyibhile kwisixhobo ngesazisi sesigulane okanye solawulo.Ukufumana iziphumo ezingcono, uvavanyo kufuneka lwenziwe kwiyure enye.
■ Yongeza amathontsi ama-3 (malunga ne-100 µl) yesampulu ekhutshiweyo kwi-Extraction Tube kwiqula lesampulu ekwikhasethi yovavanyo.
Kuphephe ukubambisa amaqamza omoya kwiqula elingumzekelo (S), kwaye musa ukulahla nasiphi na isisombululo kwifestile yokuphonononga.
Njengoko uvavanyo luqala ukusebenza, uya kubona umbala uhamba kwi-membrane.
■ Lindela amabhanti anemibala avele.Isiphumo kufuneka sifundwe ngemizuzu emi-5.Musa ukutolika umphumo emva kwemizuzu emi-5.
Lahla iityhubhu zovavanyo ezisetyenzisiweyo kunye neeCassettes zoVavanyo kwisikhongozeli esifanelekileyo senkunkuma enobungozi.
UKUTOLIKWA KWEZIPHUMO
| OKUHLEIZIPHUMO:
| Iibhanti ezimbini ezinemibala zivela kwi-membrane.Elinye iqela livela kummandla wolawulo (C) kwaye elinye ibhendi libonakala kwindawo yovavanyo (T). |
| EZINGAMBIIZIPHUMO:
| Ibhanti enye kuphela enemibala ibonakala kwindawo yokulawula (C).Akukho bhanti yemibala ebonakalayo ibonakala kwindawo yovavanyo (T). |
| AKUMELELEYOIZIPHUMO:
| Ibhendi yolawulo ayibonakali.Iziphumo zalo naluphi na uvavanyo olungakhange luvelise ibhendi yolawulo ngexesha lokufunda elichaziweyo mazichithwe.Nceda ujonge inkqubo kwaye uphinde ngovavanyo olutsha.Ukuba ingxaki iyaqhubeka, yeka ukusebenzisa ikhithi ngoko nangoko kwaye uqhagamshelane nomsasazi wakho wendawo. |
PHAWULA:
1. Ubunzima bombala kwingingqi yovavanyo (T) bunokwahluka ngokuxhomekeka kugxininiso lwezinto ezijoliswe kuzo ezikhoyo kumzekelo.Kodwa inqanaba lezinto alinakumiselwa ngolu vavanyo lomgangatho.
2. Umthamo onganeleyo wesampulu, inkqubo yokusebenza engachanekanga, okanye ukwenza iimvavanyo eziphelelwe lixesha zezona zizathu zinokwenzeka zokungaphumeleli kwebhendi yolawulo.
ULAWULO LWEMEKO
■ Ulawulo lwenkqubo lwangaphakathi lubandakanyiwe kuvavanyo.Ibhendi enemibala ebonakala kwindawo yolawulo (C) ithathwa njengolawulo olulungileyo lwangaphakathi.Iqinisekisa umthamo owaneleyo wesampuli kunye nobuchule benkqubo obuchanekileyo.
■ Ulawulo lwenkqubo lwangaphandle lunokubonelelwa (ngesicelo kuphela) kwiikhithi zokuqinisekisa ukuba iimvavanyo zisebenza ngokufanelekileyo.Kwakhona, uLawulo lunokusetyenziswa ukubonisa ukusebenza kakuhle ngumqhubi wovavanyo.Ukwenza uvavanyo oluchanekileyo okanye olubi, gcwalisa amanyathelo kwicandelo leNkqubo yoVavanyo ephatha i-swab yokulawula ngendlela efanayo ne-specimen swab.
IMIDA YOVAVANYO
1. Olu vavanyo lunokusetyenziswa kuphela ukufumanisa umgangatho we-fetal fibronectin kwiimfihlo ze-cervicovaginal.
2. Iziphumo zovavanyo kufuneka zihlale zisetyenziselwa kunye nezinye iinkcukacha zeklinikhi kunye nebhubhoratri yokulawula isigulane.
3. Imizekelo kufuneka ifunyanwe phambi koviwo lwedijithali okanye ukuguqulwa komlomo wesibeleko.Ukuguqulwa komlomo wesibeleko kunokukhokelela kwiziphumo ezingezizo ezichanekileyo.
4. Iisampuli akufanele ziqokelelwe ukuba isigulane siye sabelana ngesondo phakathi kweeyure ze-24 ukuphelisa iziphumo zobuxoki.
5. Izigulana ezinoqhambuko olukrokrelekayo okanye olwaziwayo lwe-placenta, i-placenta previa, okanye ukopha okuphakathi okanye okugqithisileyo kwilungu lobufazi akufanele kuvavanywe.
6. Izigulane ezine-cerclage akufanele zivavanywe.
7. Iimpawu zokusebenza zeStrongStep®Uvavanyo lwe-fFN lusekwe kuphononongo kubasetyhini abakhulelweyo kwi-singleton.Ukusebenza akuzange kuqinisekiswe kwizigulane ezinokumitha ezininzi, umzekelo, amawele.
8. Inyathelo elomeleleyo®Uvavanyo lwe-fFN alujoliswanga ukuba lwenziwe xa kukho ukugqabhuka kweembrane ze-amniotic kwaye ukugqabhuka kweembrane ze-amniotic kufuneka kukhutshelwe ngaphandle ngaphambi kokwenza uvavanyo.
IIMPAWU ZOKUSEBENZA
Itheyibhile: Uvavanyo lweStrongStep® fFN vs. Olunye uvavanyo lwe-brand fFN
| Uvakalelo olunxulumeneyo: 97.96% (89.13% -99.95%)* Iinkcukacha Ngokuhambelanayo: 98.73% (95.50% -99.85%)* IsiVumelwano sisonke: 98.55% (95.82% -99.70%)* *95% iThutyana lokuzithemba |
| Olunye uphawu |
| ||
| + | - | Iyonke | |||
| Inyathelo elinamandla®fFn Uvavanyo | + | 48 | 2 | 50 | |
| - | 1 | 156 | 157 | ||
|
| 49 | 158 | 207 | ||
Uvakalelo lohlalutyo
Elona nani liphantsi linokubonwa le-fFN kwisampulu ekhutshiweyo yi-50μg/L.
Phakathi kwabasetyhini abaneempawu, amanqanaba aphakamileyo (≥ 0.050 μg / mL) (1 x 10-7 mmol / L) ye-fFN phakathi kweeveki ze-24, iintsuku ze-0 kunye neeveki ze-34, iintsuku ze-6 zibonisa umngcipheko wokwanda kokunikezelwa kwi-≤ 7 okanye ≤ iintsuku eziyi-14 ukusuka ingqokelela yesampuli.Phakathi kwabasetyhini abangabonakaliyo, amanqanaba aphakamileyo e-fFN phakathi kweeveki ze-22, iintsuku ze-0 kunye neeveki ze-30, iintsuku ze-6 zibonisa umngcipheko wokwanda kokunikezelwa kwi-≤ iiveki ze-34, iintsuku ze-6 zokukhulelwa.I-cutoff ye-50 μg / L fFN yasekwa kwisifundo se-multicenter esiqhutywe ukuvavanya umbutho phakathi kwe-fetal fibronectin expression ngexesha lokukhulelwa kunye nokunikezelwa kwangaphambili.
Izinto eziphazamisayo
Kufuneka kuthatyathwe unonophelo ukuba ungangcolisi umfaki-sicelo okanye ukukhutshwa komlomo wesibeleko ngezithambiso, iisepha, izibulali ntsholongwane, okanye iikhrimu.Izithambiso okanye iikhrimu zinokuphazamisana ngokwasemzimbeni ekufunxeni komzekelo kumfaki-sicelo.Iisepha okanye izibulali ntsholongwane zinokuphazamisana ne-antibody-antigen reaction.
Izinto ezinokuthi zibe nokuphazamisa ziye zavavanywa kugxininiso ezinokufumaneka ngokufanelekileyo kwiimfihlo zomlomo wesibeleko.Ezi zinto zilandelayo azizange ziphazamise kuvavanyo xa zivavanywa kumanqanaba abonisiwe.
| Iziyobisi | Ukugxila | Iziyobisi | Ukugxila |
| Ampicillin | 1.47 mg/mL | Prostaglandin F2 | a0.033 mg/mL |
| Erythromycin | 0.272 mg/mL | Prostaglandin E2 | 0.033 mg/mL |
| Umchamo Woomama 3rd Trimester | 5% (vol) | MonistatR (miconazole) | 0.5 mg/mL |
| Oxytocin | 10 IU/mL | Indigo Carmine | 0.232 mg/mL |
| Terbutaline | 3.59 mg/mL | Gentamicin | 0.849 mg/mL |
| Dexamethasone | 2.50 mg/mL | BetadineR Gel | 10 mg/mL |
| MgSO4•7H2O | 1.49 mg/mL | BetadineR Cleanser | 10 mg/mL |
| I-Ritodrine | 0.33 mg/mL | Ijeli ye-K-YR | 62.5 mg/mL |
| DermicidolR 2000 | 25.73 mg/mL |
IINGCACISO ZONCWADI
1. IKholeji yaseMelika yeeObstetricians kunye neeGynecologists.Umsebenzi wangaphambi kwexesha.IBulletin yobuGcisa, iNombolo ye-133, ngo-Oktobha, ngo-1989.
2. I-Creasy RK, i-Resnick R. I-Maternal and Fetal Medicine: Imigaqo kunye nokuSebenza.EPhiladelphia: WB Saunders;1989.
3. Creasy RK, Merkatz IR.Ukuthintela ukuzalwa kwangaphambili: uluvo lweklinikhi.Obstet Gynecol 1990;76(Suppl 1):2S–4S.
4. UMorrison JC.Ukuzalwa kwangaphambi kwexesha: iphazili efanele ukusonjululwa.Obstet Gynecol 1990;76(Suppl 1):5S-12S.
5. Lockwood CJ, Senyei AE, Dische MR, Casal DC, et al.I-fibronectin ye-Fetal kwimfihlo yomlomo wesibeleko kunye ne-vaginal njenge-predictor yokunikezelwa kwangaphambili.IsiNgesi Esitsha J Med 1991;325:669–74.
ULUHLU LWEIMPAWU
|
| Inombolo yekhathalogu |  | Umlinganiselo wobushushu |
 | Qhagamshelana nemiyalelo yokusetyenziswa |
| Ikhowudi yebhetshi |
 | Isixhobo soxilongo lwe-in vitro |  | Sebenzisa nge |
 | Umenzi |  | Iqulathe okwaneleyoiimvavanyo |
 | Musa ukuphinda usebenzise |  | Ummeli ogunyazisiweyo kuLuntu lwaseYurophu |
 | I-CE iphawulwe ngokwe-IVD Medical Devices Directive 98/79/EC | ||
ILiming Bio-Products Co., Ltd.
No. 12 Huayuan Road, Nanjing, Jiangsu, 210042 PR China.
Umnxeba: (0086)25 85476723 Ifeksi: (0086)25 85476387
I-imeyile:sales@limingbio.com
Iwebhusayithi: www.limingbio.com
www.stddiagnostics.com
www.stidiagnostics.com
WellKang Ltd.(www.CE-marking.eu) Umnxeba: +44(20)79934346
29 Harley St., London WIG 9QR,UK Fax: +44(20)76811874
StrongStep® Fetal Fibronectin Rapid Test Isixhobo
Ukunikezelwa kwangaphambili, okuchazwa yi-American College of Obstetricians kunye neGynecologists njengokunikezelwa ngaphambi kweveki ye-37 yokukhulelwa, inoxanduva lobuninzi be-non-chromosomal perinatal morbidity kunye nokufa.Iimpawu ezisongelwayo zonikezelo lwangaphambi kwexesha zibandakanya ukuqhawuka kwesibeleko, utshintsho lokuphuma kwilungu lobufazi, ukopha kwilungu lobufazi, umqolo obuhlungu, ukungonwabi kwesisu, uxinzelelo lwe-pelvic, kunye nokuqhekeka.Iindlela zokuxilonga zokuchongwa kokunikezelwa kwangaphambili okusongelayo ziquka ukubeka iliso komsebenzi wesibeleko kunye nokusebenza kovavanyo lomlomo wesibeleko lwedijithali, oluvumela ukuqikelelwa kwemilinganiselo yomlomo wesibeleko.
IStrongStep® Fetal Fibronectin Rapid Test luvavanyo olutolikwa ngokubonwayo lwe-immunochromatographic olujoliswe ukuba lusetyenziselwe ukufunyaniswa komgangatho we-fetal fibronectin kwimfihlo yomlomo wesibeleko enezi mpawu zilandelayo:
Isebenziseka kakuhle:inkqubo yenyathelo elinye kuvavanyo lomgangatho
Ngokukhawuleza:imizuzu eyi-10 kuphela efunekayo ngexesha lokutyelela isigulane esifanayo
Akukho zixhobo:Izibhedlele ezinciphisa umthombo okanye indawo yonyango inokulwenza olu vavanyo
zinisiwe:ubushushu begumbi (2℃-30℃)
